The oncologist is considering altering the chemotherapy regimen for a patient with a refractory pancreatic tumor and liver metastases. Given the new findings of possible lung metastasis and significant anemia, what is the nurse's priority intervention to address the immediate clinical needs while awaiting the oncologist's decision?

A) Administer supplemental oxygen to manage the patient's respiratory symptoms and declining oxygen saturation.

B) Prepare for potential blood transfusion to address the patient's significant drop in hemoglobin and related symptoms.

C) Coordinate with the palliative care team to initiate aggressive pain management to improve the patient's quality of life.

D) Educate the patient and family about the potential changes in the chemotherapy regimen to alleviate anxiety.

A patient with a refractory pancreatic tumor and evidence of metastatic spread to the liver and lungs is experiencing significant symptoms including jaundice, dyspnea, and fatigue. Given the current clinical presentation and diagnostic findings, which nursing intervention should take priority to address the patient's immediate needs?

A) Administer supplemental oxygen therapy to address the patient's declining oxygen saturation and respiratory distress.

B) Initiate a blood transfusion to correct the patient's anemia and improve hemoglobin levels.

C) Coordinate with the palliative care team to develop a comprehensive pain management plan.

D) Educate the patient and family about dietary adjustments to manage elevated liver enzymes and jaundice.

A patient with known metastatic liver cancer presents with worsening respiratory distress, low oxygen saturation, and new bilateral crackles. The patient also reports severe right upper quadrant abdominal pain, and ultrasound reveals significant biliary duct dilation. Given the current clinical picture, which nursing intervention is the highest priority?

B) Collaborate with the pulmonologist to escalate respiratory support and ensure adequate oxygenation.

A) Initiate end-of-life discussions with the family to align treatment goals with patient preferences.

B) Collaborate with the pulmonologist to escalate respiratory support and ensure adequate oxygenation.

C) Prepare the patient for potential biliary drainage procedures to address the biliary obstruction.

D) Administer prescribed analgesics more frequently to manage the patient’s abdominal pain effectively.

A patient with metastatic cancer presents with worsening respiratory distress, new bilateral crackles, and acute right upper quadrant abdominal pain due to biliary obstruction. The healthcare team is considering the next steps in management. As the nurse, what is the most critical action to prioritize in the patient's care at this time?

B) Contact the hepatologist to expedite the biliary drainage procedure.

A) Increase the flow rate on the high-flow nasal cannula to improve oxygenation.

B) Contact the hepatologist to expedite the biliary drainage procedure.

C) Administer prescribed analgesics to manage the patient's abdominal pain.

D) Convene a multidisciplinary meeting to discuss palliative care options.

A patient with acute on chronic respiratory acidosis and biliary obstruction has been managed with high-flow nasal cannula, non-invasive ventilation, and ERCP with stenting. Despite these interventions, the patient continues to show signs of respiratory distress and hepatic dysfunction. What is the most appropriate nursing intervention to prioritize at this time?

C) Coordinate with the healthcare team to initiate advanced palliative care measures for symptom management.

A) Increase the FiO2 on the high-flow nasal cannula to improve oxygenation.

B) Administer a bronchodilator to alleviate respiratory distress.

C) Coordinate with the healthcare team to initiate advanced palliative care measures for symptom management.

D) Prepare the patient for potential intubation and mechanical ventilation.

A patient with a history of chronic obstructive pulmonary disease (COPD) exacerbation and recent biliary obstruction has been showing signs of acute on chronic respiratory acidosis despite interventions. What should be the nurse's priority action to improve the patient's respiratory status?

C) Collaborate with the pulmonologist to optimize non-invasive ventilation settings.

A) Increase the oxygen flow rate to 100% FiO2 to maximize oxygen delivery.

B) Prepare the patient for intubation and mechanical ventilation based on current ABG results.

C) Collaborate with the pulmonologist to optimize non-invasive ventilation settings.

D) Encourage the patient to perform incentive spirometry to improve lung expansion.

A patient who recently underwent a biliary stenting procedure is exhibiting signs of hemodynamic instability, including hypotension (BP 85/54 mmHg), tachycardia (HR 118 bpm), and symptoms of possible septicemia. The nurse is preparing to administer isotonic crystalloid solutions and broad-spectrum antibiotics. In considering the patient's complex condition, which additional nursing intervention is most critical to prioritize at this time?

B) Initiate a high-flow oxygen therapy to address potential respiratory distress.

A) Monitor the patient's urine output hourly to assess renal perfusion.

B) Initiate a high-flow oxygen therapy to address potential respiratory distress.

C) Prepare for the potential need for central venous pressure (CVP) monitoring.

D) Conduct a comprehensive neurological assessment to evaluate for hepatic encephalopathy.

A patient with recent biliary stenting presents with signs of hemodynamic instability, including hypotension, tachycardia, and fever. Blood cultures are pending, and the patient is receiving broad-spectrum antibiotics and fluid resuscitation. Which immediate nursing action is most critical to address the patient's current condition?

B) Prepare for possible intubation and mechanical ventilation.

A) Increase the rate of isotonic crystalloid infusion.

B) Prepare for possible intubation and mechanical ventilation.

C) Monitor urine output closely to assess renal function.

D) Administer acetaminophen to reduce fever and improve comfort.

A patient exhibits signs of septic shock with low blood pressure, increased heart rate, altered mental status, and elevated lactate levels. While preparing to transfer the patient to the ICU for advanced monitoring and potential vasopressor support, what is the nurse's priority action to ensure patient safety during the transition of care?

B) Provide detailed handoff communication to the receiving ICU nurse, including the patient's recent changes in vital signs and laboratory results.

A) Administer a rapid infusion of intravenous fluids to correct hypotension before the transfer.

B) Provide detailed handoff communication to the receiving ICU nurse, including the patient's recent changes in vital signs and laboratory results.

C) Monitor the patient's airway closely and prepare for possible intubation due to the shallow breathing pattern.

D) Initiate a family meeting to discuss the patient's prognosis and the need for aggressive treatment options.

A 65-year-old male patient with suspected septic shock exhibits hemodynamic instability, elevated lactate levels, and worsening organ dysfunction. Despite initial interventions, his condition continues to deteriorate. As the nurse, what is the most appropriate immediate action to prioritize in collaboration with the healthcare team to address the patient's condition?

B) Prepare for the administration of intravenous fluids and initiate vasopressor therapy

A) Increase the oxygen flow rate on the non-rebreather mask to 15 L/min

B) Prepare for the administration of intravenous fluids and initiate vasopressor therapy

C) Request an urgent consult for a palliative care evaluation

D) Administer a high-dose corticosteroid to reduce systemic inflammation

cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Uncontrolled cell proliferation due to genetic mutations in oncogenes and tumor suppressor genes disrupts normal cell cycle regulation, leading to unchecked cellular growth and tumor formation.

• Secondary mechanism: Evasion of apoptosis as cancer cells acquire mutations that inhibit programmed cell death pathways, allowing survival despite DNA damage and promoting resistance to therapies.

• Key complication: Metastasis occurs when cancer cells invade surrounding tissues and disseminate through the bloodstream or lymphatic system, establishing secondary tumors in vital organs, exacerbating disease severity and complicating treatment.

Patient Profile

Demographics:

65-year-old male, retired chemical engineer

History:

• Key past medical history: Diagnosed with stage IV pancreatic cancer; history of hypertension and type 2 diabetes

• Current medications: Chemotherapy regimen (FOLFIRINOX), Metformin, Lisinopril, Insulin, Pain management with morphine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and weight loss

• Key symptoms: Jaundice, fatigue, persistent nausea, anorexia, and back pain

• Vital signs: Blood pressure 85/55 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, temperature 101.3°F, oxygen saturation 88% on room air

Section 1

New Diagnostic Results:

The patient's recent imaging studies, including an abdominal CT scan and a PET scan, reveal significant findings that further complicate his clinical picture. The CT scan indicates that the pancreatic tumor has increased in size despite ongoing chemotherapy, suggesting a refractory nature to the current treatment regimen. Additionally, there is evidence of liver metastases, with multiple lesions noted, the largest measuring approximately 3.5 cm in diameter. These findings correlate with the elevated liver enzymes seen in the latest lab work, including AST of 145 U/L, ALT of 132 U/L, and alkaline phosphatase of 320 U/L, alongside a total bilirubin level of 6.8 mg/dL, explaining the patient's jaundice.

Concurrently, the PET scan highlights increased metabolic activity not only in the liver but also in the lungs, indicating possible metastatic spread there as well. This is supported by the recent development of respiratory symptoms such as dyspnea and a non-productive cough. Further lab tests reveal a significant drop in hemoglobin to 8.5 g/dL, suggesting possible anemia due to either chronic disease or gastrointestinal bleeding, which may be contributing to his fatigue and tachycardia.

These findings necessitate a multidisciplinary approach to reassess the patient's management plan. The oncologist considers altering the chemotherapy regimen, while the palliative care team explores additional measures for symptom relief, particularly for pain and nausea. The patient's declining oxygen saturation and increased respiratory rate warrant close monitoring and potential supplemental oxygen therapy to manage his respiratory compromise. This complex scenario challenges the clinical team to employ advanced critical thinking in balancing aggressive cancer treatment with quality-of-life considerations.

Section 2

Change in Patient Status:

As the clinical team reviews the patient's status, they observe a significant change over the next 24 hours. The patient presents with worsening respiratory distress, characterized by increased dyspnea and a respiratory rate escalating to 28 breaths per minute. His oxygen saturation on room air has dropped to 85%, necessitating the initiation of high-flow nasal cannula oxygen therapy to maintain adequate oxygenation. Despite supplemental oxygen, the patient's breath sounds reveal new bilateral crackles, suggesting potential pulmonary involvement or fluid overload, which may be exacerbating his respiratory symptoms.

Simultaneously, the patient develops acute right upper quadrant abdominal pain, rated 8 out of 10 on the pain scale, which is unrelieved by routine analgesics. An ultrasound of the abdomen is ordered, revealing significant biliary duct dilation consistent with obstructive jaundice, likely secondary to hepatic metastasis. This finding, coupled with his elevated bilirubin levels, raises concerns for potential biliary obstruction requiring intervention to prevent further hepatic dysfunction.

In response to these developments, the healthcare team convenes to discuss the implication of these findings on the patient's overall management plan. The hepatologist is consulted for possible biliary drainage procedures, while the pulmonologist evaluates the need for further respiratory support. The patient's deteriorating condition prompts a reevaluation of his treatment goals, balancing aggressive interventions with palliative measures aimed at enhancing comfort and quality of life. This delicate balance requires astute clinical judgment and ongoing reassessment as the patient’s condition continues to evolve.

Section 3

Response to Interventions:

Following the initiation of high-flow nasal cannula oxygen therapy, the patient initially exhibits a marginal improvement in oxygen saturation, rising to 90% on 60% FiO2. However, the respiratory distress persists, and his work of breathing remains significant, with accessory muscle use noted upon examination. The pulmonologist recommends escalating respiratory support to non-invasive ventilation (NIV) to address the ongoing hypoxemia and reduce the patient's respiratory effort. Despite these measures, repeat arterial blood gas analysis reveals a pH of 7.31, PaCO2 of 55 mmHg, and PaO2 of 58 mmHg, indicating acute on chronic respiratory acidosis due to potential alveolar hypoventilation and persistent V/Q mismatch.

Concurrently, the hepatologist performs an endoscopic retrograde cholangiopancreatography (ERCP) with stenting to relieve the biliary obstruction. Post-procedure, the patient reports a slight reduction in abdominal pain, now rated at 6 out of 10, and a modest decrease in serum bilirubin levels from 5.2 mg/dL to 4.1 mg/dL. Despite this, his liver function tests remain deranged, with an ALT of 165 U/L and an AST of 190 U/L, suggesting ongoing hepatic dysfunction. The interdisciplinary team discusses the importance of continued monitoring for signs of cholangitis or septicemia as potential complications of the biliary intervention.

The patient's overall status remains precarious, with a heightened risk for further complications. The team conducts a family meeting to discuss the patient's prognosis and potential escalation of care. Given the limited response to aggressive interventions, the conversation shifts towards integrating more palliative measures alongside current treatments to focus on symptom management and patient comfort. This strategic pivot requires careful deliberation, as the team must anticipate potential complications arising from both the cancer progression and treatment side effects, ensuring that the patient's evolving needs are comprehensively addressed.

Section 4

New Complications:

As the interdisciplinary team continues to monitor the patient closely, a new complication arises: the patient develops signs of hemodynamic instability. The nurse notes that the patient's blood pressure has dropped to 85/54 mmHg, and his heart rate has increased to 118 beats per minute. Concurrently, the patient reports feeling increasingly fatigued and dizzy. These symptoms raise concerns about possible septicemia, especially given his recent biliary stenting procedure and the persistent risk of cholangitis. A repeat examination reveals a low-grade fever of 100.8°F (38.2°C), and the patient appears more lethargic and diaphoretic than during previous assessments.

In response to these alarming changes, the medical team prioritizes immediate intervention to stabilize the patient's condition. Blood cultures are drawn to identify any underlying infections, and broad-spectrum intravenous antibiotics are initiated to preemptively address potential sepsis. Fluid resuscitation with isotonic crystalloid solutions is commenced to support his blood pressure and improve perfusion. Simultaneously, the team discusses adjusting the patient's respiratory support, considering the potential need for intubation and mechanical ventilation if his respiratory status continues to deteriorate.

The combination of respiratory distress, ongoing hepatic dysfunction, and now suspected sepsis requires a robust and coordinated response. The team remains vigilant for further signs of organ dysfunction, such as deteriorating renal function or worsening hepatic encephalopathy, which could complicate the management plan. This complex clinical scenario necessitates advanced critical thinking to balance aggressive treatment with the patient's comfort and quality of life, as they navigate the challenging intersection of life-sustaining interventions and palliative care.

Section 5

Change in Patient Status:

Despite the initial efforts to stabilize the patient's condition, he continues to exhibit signs of hemodynamic instability. His blood pressure remains low at 82/50 mmHg, and the heart rate has climbed further to 125 beats per minute. The patient's respiratory rate has increased to 30 breaths per minute, and he is now exhibiting shallow breathing patterns. His oxygen saturation has dropped to 89% on 4 liters of oxygen via nasal cannula, prompting the team to switch to a non-rebreather mask. The patient is becoming increasingly disoriented and confused, struggling to engage with the healthcare team, which suggests a possible onset of septic shock and encephalopathy.

Laboratory results return, showing a significant elevation in lactate levels, now at 4.5 mmol/L, which further supports the suspicion of septic shock. His liver function tests reveal worsening hepatic dysfunction, with a bilirubin level of 5.2 mg/dL and a marked increase in AST and ALT. Renal function tests indicate a rise in creatinine to 2.1 mg/dL, suggesting acute kidney injury. Blood cultures are pending, but the rapid deterioration in his clinical status necessitates urgent consideration for transfer to the intensive care unit for advanced monitoring and possible initiation of vasopressor support to maintain hemodynamic stability.

As the interdisciplinary team deliberates, they weigh the benefits of escalating care with the patient's overall prognosis and previously expressed wishes regarding intensive interventions. The patient's family is consulted to discuss the potential outcomes and the balance between aggressive treatment and the patient's quality of life. This juncture requires skilled communication, empathetic understanding, and judicious clinical judgment to navigate the complex ethical and medical decisions that lie ahead, as the path forward remains uncertain and fraught with challenges.